新薬紹介総説 新規作用機序を有する骨粗鬆症治療薬ロモソズマブ(遺伝子組換え)(イベニティ)の薬理学的特徴と臨床試験成績
Digital data available(Japan Link Center)
Begin reading now
CiNii Research
Holdings of Libraries in Japan
This page shows libraries in Japan other than the National Diet Library that hold the material.
Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.
other
CiNii Research
Search ServiceDigitalYou can check the holdings of institutions and databases with which CiNii Research is linked at the site of CiNii Research.
Bibliographic Record
You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.
- Material Type
- 記事
- Author/Editor
- 浜谷 越郎
- Author Heading
- Alternative Title
- Pharmacological characteristics and clinical study results of romosozumab (EVENITY ; genetical recombination), a drug with novel mechanism of action to treat osteoporosis at high risk of fracture
- Periodical title
- 日本薬理学雑誌 = Folia pharmacologica Japonica : くすりとからだ : ファーマコロジカ
- No. or year of volume/issue
- 155(4)=829:2020.7
- Volume
- 155
- Issue
- 4
- Sequential issue number
- 829